Catalyst Pharmaceutical Partners President Buys 50K Shares and 4 Insider Buys to Note

Mcenany Patrick J who is President and CEO at Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), bought 50,000 shares at $1.59 per share for a total value of $79,730. The shares recently traded at $1.82, up $0.23, or 14.47% since the insider buy.

O’keeffe Charles B who is Director at Catalyst Pharmaceutical Partners Inc. (NASDAQ:CPRX), bought 10,000 shares at $1.84 per share for a total value of $18,392. The shares recently traded at $1.82, down $0.02, or 1.09% since the insider buy.

cprx-20131023

Frost Phillip Md Et Al who is CEO & Chairman at Opko Health Inc (AMEX:OPK), bought 20,000 shares at $11.34 per share for a total value of $226,800. The shares recently traded at $11.1, down $0.24, or 2.12% since the insider buy.

opk-20131023

Marubeni Corp who is Director at Aircastle LTD (NYSE:AYR), bought 30,000 shares at $18.60 per share for a total value of $557,970. The shares recently traded at $18.95, up $0.35, or 1.88% since the insider buy.

ayr-20131023

Zaremba Richard A who is Senior Vice President and CFO at Misonix Inc. (NASDAQ:MSON), bought 7,500 shares at $1.82 per share for a total value of $13,650. The shares recently traded at $4.3, up $2.48, or 136.26% since the insider buy.

mson-20131023

Don’t Miss: Here’s How BP Is Drilling in Iran Despite EU Sanctions.